COMPASS THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 USD | 0.00% |
|
0.00% | +2.56% |
| 05-13 | Compass Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-06 | Top Premarket Gainers | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Bio Therapeutic Drugs | 0.00% | 0.00% | +2.56% | -49.53% | - | 220M | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- CMPX Stock
- Charts Compass Therapeutics, Inc.
- Comparison Chart
